0.00Open0.00Pre Close0 Volume0 Open Interest94.00Strike Price0.00Turnover3009.39%IV-17.93%PremiumDec 27, 2024Expiry Date14.29Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9744Delta0.0094Gamma--Leverage Ratio-69.3662Theta0.0000Rho0.00Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet